期刊文献+

芳羟基受体相互作用蛋白基因与家族性单纯性垂体腺瘤 被引量:2

Aryl Hydrocarbon Receptor Interacting Protein Gene and Familial Isolated Pituitary Adenomas
下载PDF
导出
摘要 家族性单纯性垂体腺瘤(FIPA)是一类常染色体显性疾病,其特点为低外显率、早期发病、多呈侵袭样生长及以生长激素腺瘤和泌乳素腺瘤为主。芳羟基受体相互作用蛋白基因(AIP)是抑癌基因,20%左右的FIPA家庭存在AIP杂合性突变,AIP突变导致肿瘤发生发展的分子机制目前尚不清楚。 Familial isolated pituitary adenoma(FIPA) is an autosomal dominant disease,characterized by low penetrance,early-onset disease,more invasive tumor growth,as well as somatotroph and lactotroph adenomas in most cases.It has been indicated that the aryl hydrocarbon receptor interacting protein(AIP) gene is a tumor suppressor gene.Many heterozygous mutations have been discovered in AIP in about 20% of FIPA families.However,the exact molecular mechanism by which its disfunction promotes tumorigenesis of pituitary is unclear.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2012年第6期640-644,共5页 Acta Academiae Medicinae Sinicae
关键词 芳羟基受体相互作用蛋白基因 家族性单纯性垂体腺瘤 aryl hydrocarbon receptor interacting protein gene familial pituitary adenoma
  • 相关文献

参考文献30

  • 1Beckers A, Daly AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas [J]. Eur J Endocrinol, 2007, 157(4) :371-382.
  • 2Soares BS, Eguchi K, Frohman LA. Tumor deletion mapping on chromosome 11 q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas [ J ]. J Clin Endocrinol Metab, 2005, 90 ( 12 ) : 6580- 6587.
  • 3Yamada S, Yoshimoto K, Sano T, et al. Inactivation of the tumor suppressor gene on 11 q13 in brothers with familial acrogigantism without multiple endocrine neoplasia type 1 [ J]. J Clin Endocrinol Metab, 1997, 82( 1 ) :239-242.
  • 4Daly AF, Jaffrain-Rea ML, Ciccarelli A, et al. Clinical characterization of familial isolated pituitary adenomas [ J ]. J Clin Endocrinol Metab, 2006, 91 (9) :3316-3323.
  • 5Daly AF, Vanbellinghen JF, Khoo SK, et al. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families [J]. J Clin Endocrinol Metab, 2007, 92 ( 5 ) : 1891-1896.
  • 6Georgitsi M, Raitila A, Karhu A, et al. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations [ J ]. Proc Natl Acad Sci USA, 2007, 104(10) :4101-4105.
  • 7Leontiou CA, Gueorguiev M, van der Spuy J, et al. The role of the aryl hydrocarbon receptor-interacting proteingene in familial and sporadic pituitary adenomas [ J]. J Clin Endocrinol Metab, 2008, 93 (6) :2390-2401.
  • 8Vierimaa O, Georgitsi M,Lehtonen R, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene [J]. Science, 2006, 312(5777) :1228-1230.
  • 9Igreja S, Chahal HS, King P, et al. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families [ J ]. Hum Mutat, 2010, 31(8):950-960.
  • 10Stratakis CA, Tichomirowa MA, Boikos S, et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes [J]. Clin Genet, 2010, 78(5):457-463.

同被引文献24

  • 1Vasilev V, Daly A, Naves L, et al. Clinical and genetic aspects of familial isolated pituitary adenomas [J]. Clinics (Suo Paulo), 2012, 67(Suppl ): 37-41.
  • 2Colao A, Grasso LF, Pivonello R, et al. Therapy of aggressive pituitary tumors [J]. Expert Opin Pharmacother,2011, 12(10): 1561-1570.
  • 3Daly AF, Tichomirowa/VIA, Petrossians P, et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an in- ternational collaborative study [J]. J Clin Endocrinol Metab, 2010, 95(11): E373-E383.
  • 4Oriola J, Lucas T, Halperin I, et al. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues [J]. Eur J Endocrinol, 2012, 168(1): 9-13.
  • 5Igreja S, Chahal HS, King P, et al. Characterization of aryl hydrocarbon receptor interacting protein(AIP) mutations in familial isolated pituitary adenoma families [J]. Human Mutation, 2010, 31(8): 950-960.
  • 6Cuny T, Pertuit M, Sahnoun-Fathallah M, et al. Genetic analysis in young patients with sporadic pituitary macro- adenomas: besides AIP don't forget MEN1 genetic analysis [J]. Eur J Endocrinol, 2013, 15 168(4): 533-541.
  • 7Nukaya M, Lin BC, Glover E, et ol. The aryl hydrocarbon receptor-interacting protein (AIP) is required for dioxin- induced hepatotoxicity but not for the induction of the Cyplal and Cypla2 genes [J]. J Biol Chem, 2010, 285(46): 35599-35605.
  • 8Heliovaara E, Raitila A, Launonen V, et ol. The expression of A/P-related molecules in elucidation of cellular path- ways in pituitary adenomas [J]. Am J Pathol, 2009, 175(6): 2501-2507.
  • 9Formosa R, Xuereb-Anastasi A, Vassallo J. Aip regulates cAMP signaling and GH secretion in GH3 cells [J]. Endocr Relat Cancer, 2013, 20(4): 495-505.
  • 10Moran TB, Brannick KE, Raetzma LT. Aryl-hydrocarbon receptor activity modulates prolactin expression in the pituitary [J]. Toxicol App Pharmacol, 2012, 265(1): 139-145.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部